Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Apyx Medical Corp

Get SEC filing alerts via email and in your feed for Apyx Medical Corp

APYX

Apyx Medical Corp

About Apyx Medical Corp

Apyx Medical Corporation develops and manufactures advanced energy medical devices featuring proprietary Helium Plasma Technology, marketed as Renuvion for cosmetic surgery and J-Plasma for hospital surgical applications. Serving plastic surgeons and medical professionals globally, the company offers electrosurgical generators, handpieces, and accessories that deliver precise tissue treatment with controlled heat. Its business model combines direct sales, distributor networks, OEM manufacturing, and a strong focus on innovation, clinical support, and intellectual property protection.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from Apyx Medical Corp

1
1
Apyx Medical Corp Apyx Medical Reports 32.4% Revenue Growth to $12.5 Million in Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
Apyx Medical Corp Apyx Medical Reports 9.9% Revenue Growth to $52.8 Million for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Apyx Medical Corp Apyx Medical Corporation Reports Q3 2025 Financial Results with 12.1% Revenue Growth

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Apyx Medical Corp Apyx Medical Reports 6.4% Revenue Decline and Net Loss Improvement in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Apyx Medical Corp Apyx Medical Reports $9.43 Million Revenue in Q1 2025, Down 7.9% Year-Over-Year

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Apyx Medical Corp Apyx Medical Reports $48.1 Million Revenue for Fiscal Year 2024, Implements Cost-Saving Restructuring

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
Apyx Medical Corp Apyx Medical Reports Decline in Revenue and Increased Net Losses for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments